Drug
3 75 Imiquimod
3 75 Imiquimod: highest development phase Not Applicable, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| 3.75% Imiquimod Cream NCT02301494 | Not Applicable | Mycosis Fungoides |
Latest
No recent events.
Follow 3 75 Imiquimod on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.